Orly - 120 mg 30 Capsules

Obesity (combined with a moderate calorie diet)

Trade name: Orly

Orly

Compound: Each capsule contains:

Orlistat 120 mg

Auxiliary components: microcrystalline cellulose, sodium carboxymethyl starch, sodium lauryl sulfate, povidone K30, proprietary blue dye, titanium dioxide, gelatin

Properties: Lipase inhibitor. When taken orally, orlistat inhibits gastric and pancreatic lipases. As a result, the breakdown of dietary fats is disrupted and their absorption from the gastrointestinal tract is reduced. With systematic use, this effect leads to a decrease in body weight in obese patients. Orlistat is practically not absorbed from the gastrointestinal tract and therefore has practically no resorptive effect

Indications: Obesity (combined with a moderate calorie diet)

Dosage and administration: The optimal dosage regimen is determined by the doctor Compliance of the dosage form of a particular drug with indications for use and dosing regimen should be strictly observed

inside. The recommended dose is 120 mg 3 times / day with meals

The duration of the course of treatment is no more than 6 months

Contraindications: Hypersensitivity to orlistat; chronic malabsorption syndrome, cholestasis; simultaneous use with warfarin or other oral anticoagulants of indirect action, concomitant therapy with cyclosporine, simultaneous use with sitagliptin; pregnancy, lactation (breastfeeding); children and adolescents up to 18 years of age

Precautionary measures: Diet and exercise are an important component of a weight loss program. It is recommended that diet and exercise be initiated prior to initiating orlistat therapy. During the period of use of orlistat, the patient should receive a moderately hypocaloric diet with a balanced content of nutrients, in which approximately 30% is fat. It is recommended that the food be rich in fruits and vegetables. The diet and exercise program should continue after orlistat is discontinued.

It must be borne in mind that the frequency and severity of side effects increase with increasing fat content in food. By reducing the fat content in food, the likelihood of side effects decreases. It is recommended that the amount of fat consumed per day be fairly evenly distributed over all meals

If diarrhea occurs during the use of orlistat, the use of an additional method of contraception is recommended to prevent the possible ineffectiveness of oral contraceptives

If symptoms such as weakness, fatigue, fever, jaundice and dark urine appear, you should consult your doctor to rule out liver dysfunction

Side effects: From the digestive system: very often — oily discharge from the rectum, passing gases with some discharge, imperative urge to defecate, steatorrhea, flatulence

often — abdominal pain, fecal incontinence, loose stools, increased bowel movements

frequency is unknown — minor bleeding from the rectum, diverticulitis, pancreatitis

From the side of the liver and biliary tract: the frequency is unknown — increased activity of «liver» transaminases, alkaline phosphatase, hepatitis, cholelithiasis

From the urinary system: the frequency is unknown — hyperoxalaturia, oxalate nephropathy, which can sometimes lead to the development of renal failure

From the skin and subcutaneous tissues: the frequency is unknown — bullous rash.

Other: the frequency is unknown — a feeling of anxiety; with the simultaneous use of orlistat and anticoagulants of indirect action, there was a decrease in the concentration of prothrombin in the blood plasma and an increase in the international normalized ratio (INR)

Storage method: Store at a temperature not exceeding 30 degrees.

Package: The cardboard box contains 1, 2 or 3 blisters of 10 capsules.